Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1

Kaijun Jin; Hong Yin; De Clercq Erik; Christophe Pannecouque; Ge Meng; Fen‐Er Chen

doi:10.1016/j.ejmech.2018.01.016

Back

Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1

Article 2018 en

Related publications

Article2017

Discovery of Biphenyl-Substituted Diarylpyrimidines as New Non-Nucleoside HIV-1 Reverse Transcripttase Inhibitors

Kaijun Jin, Ge Meng, Fen‐Er Chen, De Clercq Erik, Christophe Pannecouque

Article2007

Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains

Maria Letizia Barreca, Angela Rao, Laura De Luca, Nunzio Iraci, Anna‐Maria Monforte, Giovanni Maga, De Clercq Erik, Christophe Pannecouque, Jan Balzarini, Alba Chimirri

Article2007

Discovery of Novel Benzimidazolones as Potent Non‐Nucleoside Reverse Transcriptase Inhibitors Active Against Wild‐Type and Mutant HIV‐1 Strains.

Maria Letizia Barreca, Angela Rao, Laura De Luca, Nunzio Iraci, Anna‐Maria Monforte, Giovanni Maga, De Clercq Erik, Christophe Pannecouque, Jan Balzarini, Alba Chimirri

Article2025

Halogenation-Driven Discovery of Halomethylene-Biphenyl-Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Safety and PK Profiles

Xiaomei Chen, Qian Xu, Christophe Pannecouque, De Clercq Erik, Enzo Tramontano, Phuong‐Thao Tran, Shuai Wang, Fen‐Er Chen

Article2024

Identification of novel diarylpyrimidine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against wild-type and K103N mutant viruses

Xiangyi Jiang, Waleed A. Zalloum, Zhen Gao, Jiaojiao Dai, Xiangkai Ji, Minghui Xie, Guanyu Dong, De Clercq Erik, Boshi Huang, Christophe Pannecouque, Peng Zhan, Xinyong Liu

Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1

Discussion(0)

Related publications

Discovery of Biphenyl-Substituted Diarylpyrimidines as New Non-Nucleoside HIV-1 Reverse Transcripttase Inhibitors

Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains

Discovery of Novel Benzimidazolones as Potent Non‐Nucleoside Reverse Transcriptase Inhibitors Active Against Wild‐Type and Mutant HIV‐1 Strains.

Halogenation-Driven Discovery of Halomethylene-Biphenyl-Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Safety and PK Profiles

Identification of novel diarylpyrimidine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against wild-type and K103N mutant viruses